Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK

Published: 11/09/2019
Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK
Source: WWW.BUSINESSWIRE.COM

SAN DIEGO--(BUSINESS WIRE)--<a href="https://twitter.com/hashtag/SanDiego?src=hash" target="_blank">#SanDiego</a>--GSK to acquire Sitari Pharmaceuticals, which has been developing a transglutaminase 2 small molecule program for the treatment of celiac disease.

Read more
Related news
Comment
Latest in blog
FACEBOOK